Armstrong, A.; Agada, N.; Xu, W.; Gallo, G. An Update on the Long-Term Safety Experience of Ixekizumab: Results from the Psoriasis Clinical Development Program With More Than 3 Years of Follow-up from 12 Clinical Trials and More Than 15000 Patient-Years of Exposure to Ixekizumab. J of Skin 2018, 2, S116.